-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vamikibart in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vamikibart in Diabetic Macular Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vamikibart in Diabetic Macular Edema Drug Details: Vamikibart is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vamikibart in Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vamikibart in Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vamikibart in Uveitis Drug Details: Vamikibart is under development for the treatment...
-
Product Insights
NewCastle Biosciences Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Castle Biosciences Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Castle Biosciences Inc (Castle Biosciences) develops and commercializes diagnostic and prognostic tests for dermatologic cancers. The company’s product portfolio includes DecisionDx-Melanoma to identify the recurrence of melanoma; DecisionDx-CMSeq, a 3-gene test developed to spot somatic mutations associated with cutaneous melanoma; DecisionDx-UM, a proprietary GEP (gene expression profile) test used to anticipate the risk of metastatic uveal melanoma; DecisionDx-UMSeq to...
-
Analyst Opinions
NewMobile World Congress (MWC) 2024 – Startups Race for Digital Change
Mobile World Congress (MWC) 2024 Report Overview MWC (Mobile World Congress) is a premier global event for the mobile technology industry, while 4YFN (4 Years from Now) is its associated platform focusing on connecting startups with investors and partners to drive innovation. With over 40 companies in attendance, AI startups took center stage at MWC 2024, signaling robust investor and market interest in AI as the key driver for future innovation. Beyond AI, fintech, digitalization, IoT, digital media, and health...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vamikibart in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vamikibart in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vamikibart in Diabetic Macular Edema Drug Details: Vamikibart is under development...
-
Product Insights
UM Uckermark Wind Park
UM Uckermark Wind Park is an Onshore Wind project located in Brandenburg, Germany. The project came online in 2010. Empower your strategies with our UM Uckermark Wind Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vamikibart in Uveitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vamikibart in Uveitis Drug Details: Vamikibart is under development for the treatment of diabetic macular...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EBI-031 in Diabetic Macular Edema
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EBI-031 in Diabetic Macular Edema Drug Details:RG-6179 (EBI-031) is under development for the treatment of diabetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EBI-031 in Uveitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EBI-031 in Uveitis Drug Details:RG-6179 (EBI-031) is under development for the treatment of diabetic macular edema...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palmidrol in Fibromyalgia (Fibromyalgia Syndrome)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Palmidrol in Fibromyalgia (Fibromyalgia Syndrome) Drug Details: Palmidrol (FSD-201) is under development for the treatment...